STOCK TITAN

Registration is Now Open for Tribe Public’s Webinar Event "Diabetes Care Innovator Modular Medical Takes Next Steps" Featuring Modular Medical CEO on Friday, August 9, 2024

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Positive)
Tags

Modular Medical (NASDAQ:MODD), a development-stage insulin delivery technology company, announces CEO Jeb Besser's upcoming presentation at Tribe Public's Webinar on August 9, 2024. The event, titled 'Diabetes Care Innovator Modular Medical Takes Next Steps', will showcase the company's efforts in developing user-friendly and affordable insulin pump technology.

The webinar comes amid projections of significant growth in the global diabetes care market, expected to reach $35.8 billion by 2028 from $18.9 billion in 2023. The insulin pump segment alone is forecasted to grow from $5.26 billion to $21.65 billion by 2032. Modular Medical aims to capitalize on this growth with its MODD1 technology, designed to empower the diabetes community.

Modular Medical (NASDAQ:MODD), un'azienda in fase di sviluppo di tecnologie per la somministrazione dell'insulina, annuncia la prossima presentazione del CEO Jeb Besser al webinar di Tribe Public, che si terrà il 9 agosto 2024. L'evento, intitolato 'Diabetes Care Innovator Modular Medical Takes Next Steps', metterà in evidenza gli sforzi dell'azienda nello sviluppo di una tecnologia per pompe insuliniche user-friendly e accessibile.

Il webinar arriva in un momento di proiezioni di crescita significativa nel mercato globale della cura del diabete, che si prevede raggiunga 35,8 miliardi di dollari entro il 2028, rispetto ai 18,9 miliardi di dollari nel 2023. Solo il segmento delle pompe insuliniche è previsto crescere da 5,26 miliardi a 21,65 miliardi di dollari entro il 2032. Modular Medical mira a sfruttare questa crescita con la sua tecnologia MODD1, progettata per supportare la comunità diabetica.

Modular Medical (NASDAQ:MODD), una empresa en etapa de desarrollo de tecnologías para la entrega de insulina, anuncia la próxima presentación del CEO Jeb Besser en el seminario web de Tribe Public que se llevará a cabo el 9 de agosto de 2024. El evento, titulado 'Diabetes Care Innovator Modular Medical Takes Next Steps', mostrará los esfuerzos de la empresa en desarrollar una tecnología de bomba de insulina amigable para el usuario y asequible.

El seminario web llega en un momento de proyecciones de crecimiento significativo en el mercado global de atención de la diabetes, que se espera alcance 35.8 mil millones de dólares para 2028, frente a los 18.9 mil millones de dólares en 2023. Se prevé que el segmento de bombas de insulina crezca de 5.26 mil millones a 21.65 mil millones de dólares para 2032. Modular Medical busca capitalizar este crecimiento con su tecnología MODD1, diseñada para empoderar a la comunidad diabética.

모듈러 메디컬(NASDAQ:MODD)은 인슐린 전달 기술을 개발 중인 회사로, CEO 제브 베서(Jeb Besser)의 2024년 8월 9일 Tribe Public의 웨비나에서의 발표를 알립니다. '당뇨 관리 혁신가 모듈러 메디컬, 다음 단계로 나아가다'라는 제목의 이 이벤트는 사용자 친화적이고 저렴한 인슐린 펌프 기술 개발에 대한 회사의 노력을 소개할 것입니다.

이번 웨비나는 글로벌 당뇨 관리 시장에서의 상당한 성장 예상 속에 열리며, 이 시장은 2023년 189억 달러에서 2028년까지 358억 달러에 이를 것으로 예상됩니다. 인슐린 펌프 부문만도 52억 6천만 달러에서 2032년까지 216억 5천만 달러에 이를 것이라고 전망하고 있습니다. 모듈러 메디컬은 이 성장 가능성을 MODD1 기술로 활용하고자 하며, 이는 당뇨병 커뮤니티에 힘을 실어주는 것을 목표로 합니다.

Modular Medical (NASDAQ:MODD), une entreprise en phase de développement de technologies de livraison d'insuline, annonce la prochaine présentation de son PDG Jeb Besser lors du webinaire de Tribe Public, qui aura lieu le 9 août 2024. L'événement, intitulé 'Diabetes Care Innovator Modular Medical Takes Next Steps', mettra en valeur les efforts de l'entreprise pour développer une technologie de pompe à insuline conviviale et abordable.

Le webinaire intervient dans un contexte de prévisions de croissance significative sur le marché mondial des soins du diabète, qui devrait atteindre 35,8 milliards de dollars d'ici 2028, contre 18,9 milliards de dollars en 2023. Le segment des pompes à insuline devrait passer de 5,26 milliards de dollars à 21,65 milliards de dollars d'ici 2032. Modular Medical vise à tirer parti de cette croissance avec sa technologie MODD1, conçue pour autonomiser la communauté diabétique.

Modular Medical (NASDAQ:MODD), ein Unternehmen in der Entwicklungsphase für Insulinabgabetchnologien, kündigt die bevorstehende Präsentation des CEO Jeb Besser beim Webinar von Tribe Public am 9. August 2024 an. Die Veranstaltung mit dem Titel 'Diabetes Care Innovator Modular Medical Takes Next Steps' wird die Bemühungen des Unternehmens vorstellen, benutzerfreundliche und erschwingliche Insulinpumpentechnologie zu entwickeln.

Das Webinar findet vor dem Hintergrund prognostizierten signifikanten Wachstums im globalen Diabetesmarkt statt, der voraussichtlich bis 2028 35,8 Milliarden USD erreichen wird, im Vergleich zu 18,9 Milliarden USD im Jahr 2023. Allein der Insulinpumpensegment wird von 5,26 Milliarden USD auf 21,65 Milliarden USD bis 2032 anwachsen. Modular Medical plant, mit seiner MODD1-Technologie von diesem Wachstum zu profitieren, die darauf ausgelegt ist, die Diabetesgemeinschaft zu stärken.

Positive
  • Modular Medical is positioning itself in a rapidly growing diabetes care market
  • The insulin pump segment is projected to grow significantly, from $5.26 billion to $21.65 billion by 2032
  • The company is developing user-friendly and affordable insulin pump technology, potentially addressing a market need
Negative
  • Modular Medical is still in the development stage, without a market-ready product
  • The company faces potential competition in a growing market with established players
  • The global diabetes care market, valued at $18.9 billion in 2023, is projected to reach $35.8 billion by 2028

  • The insulin pump segment is expected to grow from $5.26 billion to $21.65 billion by 2032

  • Discover how Modular Medical is accelerating the development of technology to empower the whole diabetes community with MODD1

  • Meet with Modular Medical CEO Jeb Besser

SAN DIEGO, CA / ACCESSWIRE / August 8, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a development-stage, insulin delivery technology company seeking to launch the next generation of user-friendly and affordable insulin pump technology, today announced that Jeb Besser, CEO of Modular Medical, will present at Tribe Public's Webinar Presentation and Q&A Event titled "Diabetes Care Innovator Modular

Medical Takes Next Steps." The Event is scheduled to begin at 8:30am pacific/11:30am eastern on Friday, August 9, 2024. To register to join the complimentary event, please visit the Tribe Public LLC at MODDAugust92024.TribePublic.com.

Once registered, participants may begin forwarding their questions for the CEO to Tribe Public at research@tribepublic.com or share their questions via the ZOOM chat feature during the event. Tribe Public's Managing Member, John F. Heerdink, Jr., will host the event and relay all questions to management.

About Modular Medical

Modular Medical, Inc. (NASDAQ:MODD) is a development-stage medical device company that intends to launch the next generation of insulin delivery technology. Using its patented technologies, the Company seeks to eliminate the tradeoff between complexity and efficacy, thereby making top quality insulin delivery both affordable and simple to learn. The Company's mission is to improve access to the highest standard of glycemic control for people with diabetes taking it beyond "superusers" and providing "diabetes care for the rest of us." Modular Medical was founded by Paul DiPerna, a seasoned medical device professional and microfluidics engineer. Prior to founding Modular Medical, Mr. DiPerna was the founder (in 2005) of Tandem Diabetes and invented and designed its t:slim insulin pump. More information is available at https://modular-medical.com.

All trademarks mentioned herein are the property of their respective owners.

ABOUT TRIBE PUBLIC LLC

Tribe Public LLC is a San Francisco, CA based organization that hosts complimentary worldwide webinar & meeting events in the U.S. Tribe's complimentary events focus on issues that the Tribe members care about with an emphasis on hosting management teams from publicly traded companies from all sectors & financial organizations that are seeking to increase awareness of their products, progress and plans. Tribe members primarily include Family Offices, Portfolio Managers, Registered Investment Advisors, Accredited Investors, Sell Side Analysts, and members of media. Tribe Members are encouraged to express their interest in speakers they care about and want to learn from at the Tribe Public website via the Tribe's FREE "Wish List" process. Visit Tribe Public's Website to learn more: http://www.tribepublic.com/

CONTACT:

Jeb Besser
Chief Executive Officer
Modular Medical, Inc.
+1 (617) 399-1741
IR@modular-medical.com

SOURCE: Modular Medical, Inc.



View the original press release on accesswire.com

FAQ

When is Modular Medical's CEO presenting at the Tribe Public Webinar?

Modular Medical's CEO, Jeb Besser, is scheduled to present at Tribe Public's Webinar on Friday, August 9, 2024, at 8:30am Pacific/11:30am Eastern time.

What is the projected growth of the global diabetes care market?

The global diabetes care market is projected to grow from $18.9 billion in 2023 to $35.8 billion by 2028.

What is the expected growth of the insulin pump segment?

The insulin pump segment is expected to grow from $5.26 billion to $21.65 billion by 2032.

What is Modular Medical's stock symbol?

Modular Medical's stock symbol is MODD, and it is listed on NASDAQ.

What is the focus of Modular Medical's technology development?

Modular Medical is focusing on developing user-friendly and affordable insulin pump technology, specifically their MODD1 product.

Modular Medical, Inc.

NASDAQ:MODD

MODD Rankings

MODD Latest News

MODD Stock Data

68.05M
29.29M
10.05%
44.12%
1.99%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
SAN DIEGO